Enliven Therapeutics, Inc. (ELVN)
49.45
-0.79
(-1.57%)
USD |
NASDAQ |
Sep 18, 16:00
49.45
0.00 (0.00%)
Pre-Market: 08:53
Enliven Therapeutics Net Income (TTM) : -105.93M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -105.93M |
| March 31, 2026 | -98.78M |
| December 31, 2025 | -103.69M |
| September 30, 2025 | -97.21M |
| June 30, 2025 | -100.22M |
| March 31, 2025 | -94.83M |
| December 31, 2024 | -89.02M |
| September 30, 2024 | -85.21M |
| June 30, 2024 | -82.83M |
| March 31, 2024 | -79.60M |
| December 31, 2023 | -71.58M |
| September 30, 2023 | -20.03M |
| June 30, 2023 | -9.814M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.982M |
| December 31, 2022 | 4.073M |
| September 30, 2022 | -42.43M |
| June 30, 2022 | -45.52M |
| March 31, 2022 | -49.80M |
| December 31, 2021 | -51.38M |
| September 30, 2021 | -48.58M |
| June 30, 2021 | -47.36M |
| March 31, 2021 | -44.40M |
| December 31, 2020 | -41.36M |
| September 30, 2020 | -37.09M |
| June 30, 2020 | -31.29M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Definium Therapeutics, Inc. | -353.78M |
| Cocrystal Pharma, Inc. | -9.938M |
| CNBX Pharmaceuticals, Inc. | -0.4621M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 9.30M |